Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anatomical, histomorphological and molecular classification of cholangiocarcinoma
Timothy J. Kendall, Joanne Verheij, Eugenio Gaudio, et al.
Liver International (2019) Vol. 39, Iss. S1, pp. 7-18
Open Access | Times Cited: 267

Showing 26-50 of 267 citing articles:

Prognostic and Predictive Molecular Markers in Cholangiocarcinoma
Sandra Pavicevic, Sophie Reichelt, Deniz Uluk, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1026-1026
Open Access | Times Cited: 31
Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
Hee Seung Lee, Dai Hoon Han, Kyungjoo Cho, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing
Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, et al.
Cancer Treatment Reviews (2023) Vol. 122, pp. 102649-102649
Open Access | Times Cited: 19
SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment
Ralf‐Peter Czekay, Craig E. Higgins, Hasan Basri Aydin, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 796-796
Open Access | Times Cited: 8
Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper
Matteo Fassan, Valentina Angerilli, Nicola Normanno, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 194, pp. 104224-104224
Open Access | Times Cited: 7
LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling
YU Shaobo, Xin Gao, Sidi Liu, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 4, pp. 552-561
Closed Access | Times Cited: 7
Cuproptosis-related genes score and its hub gene GCSH: A novel predictor for cholangiocarcinomas prognosis based on RNA seq and experimental analyses
Rui He, Yihu Li, Pengcheng Jiao, et al.
Journal of Cancer (2024) Vol. 15, Iss. 6, pp. 1551-1567
Open Access | Times Cited: 6
TGFβ-induced long non-coding RNA LINC00313 activates Wnt signaling and promotes cholangiocarcinoma
Panagiotis Papoutsoglou, Raphaël Pineau, Raffaële Leroux, et al.
EMBO Reports (2024) Vol. 25, Iss. 3, pp. 1022-1054
Open Access | Times Cited: 6
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging
Domenico Alvaro, Cesare Hassan, Vincenzo Cardinale, et al.
Digestive and Liver Disease (2020) Vol. 52, Iss. 11, pp. 1282-1293
Closed Access | Times Cited: 47
Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine
Ines Malenica, Matteo Donadon, Ana Lleò
Cancers (2020) Vol. 12, Iss. 8, pp. 2190-2190
Open Access | Times Cited: 44
Immunotherapy in Advanced Biliary Tract Cancers
Alice Boilève, Marc Hilmi, Cristina Smolenschi, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1569-1569
Open Access | Times Cited: 33
Precision Medicine in Biliary Tract Cancer
Aaron J. Scott, Reya Sharman, Rachna T. Shroff
Journal of Clinical Oncology (2022) Vol. 40, Iss. 24, pp. 2716-2734
Closed Access | Times Cited: 28
Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice
Elvire Desjonquieres, Claudia Campani, Fabio Marra, et al.
Liver International (2022) Vol. 42, Iss. 3, pp. 492-506
Closed Access | Times Cited: 27
Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review
Mukul Vij, Yogesh Puri, Ashwin Rammohan, et al.
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 3, pp. 607-627
Open Access | Times Cited: 24
Pathologies of Precursor Lesions of Biliary Tract Carcinoma
Yasuni Nakanuma, Yuko Kakuda, Takashi Sugino, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5358-5358
Open Access | Times Cited: 24
Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision Medicine
Purva Gopal, Marie E. Robert, Xuchen Zhang
Archives of Pathology & Laboratory Medicine (2023) Vol. 148, Iss. 3, pp. 359-370
Open Access | Times Cited: 16
A transcriptome based molecular classification scheme for cholangiocarcinoma and subtype-derived prognostic biomarker
Zhongqi Fan, Xinchen Zou, Guangyi Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Recent Advances in Pathology of Intrahepatic Cholangiocarcinoma
Joon Hyuk Choi, Swan N. Thung
Cancers (2024) Vol. 16, Iss. 8, pp. 1537-1537
Open Access | Times Cited: 5
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression
Alphonse E. Sirica, Mario Strazzabosco, Massimiliano Cadamuro
Advances in cancer research (2020), pp. 321-387
Open Access | Times Cited: 37
Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression
Jittima Tomacha, Hasaya Dokduang, Sureerat Padthaisong, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 30
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers
Lei Shi, William Shen, Mindy I. Davis, et al.
Nature Cancer (2023) Vol. 4, Iss. 3, pp. 365-381
Open Access | Times Cited: 13
Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version)
Han Wang, Jun Chen, Xin Zhang, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 11, Iss. 7, pp. 1553-1564
Open Access | Times Cited: 12
An overview of extrahepatic cholangiocarcinoma: from here to where?
Yongheng Yang, Xiaolu Zhang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Application of AI on cholangiocarcinoma
Jianhao Huang, Xuesong Bai, Yan-Yu Qiu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Circ_0007534 promotes cholangiocarcinoma stemness and resistance to anoikis through DDX3X-mediated positive feedback regulation of parental gene DDX42
Sidi Liu, Canghai Guan, Xiangjun Sha, et al.
Cellular Signalling (2024) Vol. 118, pp. 111141-111141
Closed Access | Times Cited: 4

Scroll to top